Kura Oncology Inc

NASDAQ KURA

Data sourced from iex and EODHD
Download Data

Kura Oncology Inc Income Statement 2008 - 2023

This table shows the Income Statement for Kura Oncology Inc going from 2008 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2011-12-31 2010-12-31 2009-12-31 2008-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 - - - - - -
Cost of Revenue
M 1 1 1 0 - 0 0 0 0 0 0 0 0 0 0 -
Gross Profit
M -1 -1 -1 0 - 0 0 0 0 0 0 0 0 0 0 -
Operating Expenses
M 165 140 131 92 - 63 36 28 24 4 0 0 0 0 0 -
Selling, General, and Administrative Expenses (SG&A)
M 51 47 47 32 20 16 10 8 6 1 0 0 0 0 0 -
Research and Development (R&D) Expenses
M 115 93 85 60 48 47 26 20 18 1 - - - - - -
Other Operating Expenses
M -1 0 0 0 - 0 0 0 0 2 - - - - - -
Costs and Expenses
M 164 139 131 92 - 63 36 28 24 4 0 0 0 0 0 -
Operating Income
M -166 -141 -132 -92 -67 -63 -36 -28 -24 -4 0 0 0 0 0 0
Interest Expense
M 2 0 0 1 1 1 1 1 0 0 0 0 0 0 0 -
Non-operating Income/Expense
M 13 5 1 2 4 2 1 1 1 0 0 0 0 0 0 -
EBT
M -153 -136 -130 -90 -63 -60 -35 -28 -23 -4 0 0 0 0 0 0
Income Tax Provision
M - 0 -1 0 -5 3 0 0 0 0 - - - - - -
Income after Tax
M - -136 -130 -89 -58 -64 -35 -28 -23 -4 - - - - - -
Non-Controlling Interest
M - 0 0 0 0 0 0 0 0 0 0 0 - - - -
Net Income
M - -136 -130 -90 -63 -60 -35 -28 -23 0 0 0 - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 73,229,000.00 66,989,999.00 66,352,000.00 53,077,000.00 41,946,000.00 35,191,000.00 23,237,000.00 18,701,000.00 9,933,000.00 14,508,180.00 5,000,000.00 5,000,000.00 5,000,000.00 5,000,000.00 5,000,000.00 -
EBITDA
M -165 -140 -131 -92 -67 -63 -36 -28 -24 -4 0 0 0 0 0 0
Depreciation and Amortization
M 1 1 1 0 - 0 0 0 0 0 - - - - - -
EBIT
M -166 -141 -132 -92 -63 -63 -36 -28 -24 -4 0 0 0 - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% - -0.17 0.43 0.22 7.79 -5.63 0.08 0.11 0.09 -7.32 - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0 0 0 0 0 0 0 0 - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email